These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34957104)

  • 1. Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma.
    Xu W; Zhu W; Tian X; Liu W; Wu Y; Anwaier A; Su J; Wei S; Qu Y; Zhang H; Ye D
    Front Cell Dev Biol; 2021; 9():772436. PubMed ID: 34957104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
    Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
    Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-cell and spatial transcriptomics reveal 5-methylcytosine RNA methylation regulators immunologically reprograms tumor microenvironment characterizations, immunotherapy response and precision treatment of clear cell renal cell carcinoma.
    Gui CP; Wei JH; Zhang C; Tang YM; Shu GN; Wu RP; Luo JH
    Transl Oncol; 2023 Sep; 35():101726. PubMed ID: 37379773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma.
    Chen C; Chen LY; Zhang JX; Xu HG
    Curr Oncol; 2022 Dec; 30(1):559-574. PubMed ID: 36661693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
    Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
    J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Xu W; Tian X; Liu W; Anwaier A; Su J; Zhu W; Wan F; Shi G; Wei G; Qu Y; Zhang H; Ye D
    Front Oncol; 2021; 11():709579. PubMed ID: 34295828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of m
    Pei D; Xu C; Wang D; Shi X; Zhang Y; Liu Y; Liu N; Guo J; Yu Y; Kang Z; Zhu H
    J Oncol; 2022; 2022():2910491. PubMed ID: 35281520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
    Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
    Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment.
    Xu W; Anwaier A; Ma C; Liu W; Tian X; Su J; Zhu W; Shi G; Wei S; Xu H; Qu Y; Ye D; Zhang H
    Front Cell Dev Biol; 2021; 9():785410. PubMed ID: 34938737
    [No Abstract]   [Full Text] [Related]  

  • 11. m6A Methylation Patterns and Tumor Microenvironment Infiltration Characterization in Clear-Cell Renal Cell Carcinoma.
    Ma T; Wang J; Liu X; Zhang W; Meng L; Zhang Y
    Front Genet; 2022; 13():864549. PubMed ID: 35528542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma.
    Anwaier A; Xu W; Liu W; Wei S; Tian X; Qu Y; Yang J; Zhang H; Ye D
    J Natl Cancer Cent; 2023 Sep; 3(3):236-249. PubMed ID: 39035192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
    Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
    Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA m
    Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
    Front Immunol; 2022; 13():905057. PubMed ID: 36389669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Li F; Deng Q; Pang X; Huang S; Zhang J; Zhu X; Chen H; Liu X
    Front Oncol; 2021; 11():729887. PubMed ID: 34804923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients.
    Xiong Y; Wang Z; Zhou Q; Zeng H; Zhang H; Liu Z; Huang Q; Wang J; Chang Y; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Bai Q; Guo J; Xu J
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
    Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m
    Wen Q; Wang S; Hong L; Shen S; He Y; Sheng X; Zhuang X; Chen S; Wang Y; Zhuang H
    Immun Inflamm Dis; 2024 Jan; 12(1):e1150. PubMed ID: 38270308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Zhong J; Liu Z; Cai C; Duan X; Deng T; Zeng G
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy.
    Zhong W; Li Y; Yuan Y; Zhong H; Huang C; Huang J; Lin Y; Huang J
    Front Cell Dev Biol; 2021; 9():736540. PubMed ID: 34631713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.